These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 30041818)

  • 1. HPV vaccination and the effects on rates of HPV-related cancers.
    St Laurent J; Luckett R; Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):493-506. PubMed ID: 30041818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
    Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
    Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening the case for gender-neutral and the nonavalent HPV vaccine.
    Hintze JM; O'Neill JP
    Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):857-865. PubMed ID: 29327306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of human papillomavirus vaccines and beyond.
    Lehtinen M; Dillner J
    Nat Rev Clin Oncol; 2013 Jul; 10(7):400-10. PubMed ID: 23736648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting to know human papillomavirus (HPV) and the HPV vaccines.
    Smith GD; Travis L
    J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current data on the efficacy of prophylactic HPV vaccination in the primary prevention of cervical lesions.
    Sehnal Borek; Driák Daniel; Džubáková Nipčová Monika; Sláma Jiří
    Ceska Gynekol; 2022; 87(2):124-130. PubMed ID: 35667864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.
    Kamolratanakul S; Pitisuttithum P
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
    Mahoney MC
    J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-related cancers-we can prevent them and we should.
    Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):456. PubMed ID: 30111490
    [No Abstract]   [Full Text] [Related]  

  • 17. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
    Pitisuttithum P; Velicer C; Luxembourg A
    Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human papillomavirus nonavalent vaccine. Update 2017].
    Bosch FX; Moreno D; Redondo E; Torné A
    Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
    Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
    BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.